Publications by authors named "G Kovac"

Developmental psychologists have long-established socio-cognitive abilities as fundamental to human intelligence and development. These abilities enable individuals to enter, learn from, and contribute to a surrounding culture. This drives the process of cumulative cultural evolution, which is responsible for humanity's most remarkable achievements.

View Article and Find Full Text PDF

The standard way to study Large Language Models (LLMs) through benchmarks or psychology questionnaires is to provide many different queries from similar minimal contexts (e.g. multiple choice questions).

View Article and Find Full Text PDF
Article Synopsis
  • Current trends in drug design focus on privileged scaffolds, which are key structural components that enhance a drug's effectiveness by improving its affinity to biological targets and reducing toxicity.
  • Fruquintinib is a new selective inhibitor of VEGFR isoforms, designed to treat metastatic colorectal cancer, featuring a unique bicyclic heteroaromatic structure that includes amide groups for hydrogen bonding.
  • The article discusses fruquintinib's pharmacodynamics, its molecular properties, and how these relate to its pharmacokinetics and potential to cross the blood-brain barrier, along with insights into clinical experiences and future research directions.
View Article and Find Full Text PDF

Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has plagued the human population as 2019 turned into 2020, when first cases were confirmed to be infected with the pathogen in Wuhan City, the largest mega-city and capital of Hubei Province in Central China. Since this time, many pharmacotherapeutic modalities were suggested and used to treat the patients suffering from COVID-19. Triazavirin (TZV; riamilovir) is a synthetic non-toxic broad-spectrum antiviral drug belonging into an azolotriazine class.

View Article and Find Full Text PDF

High prevalence and stronger emergency of various forms of drug-resistant tuberculosis (DR-TB), including the multidrug-resistant (MDR-TB) as well as extensively drug-resistant (XDR-TB) ones, caused by variously resistant Mycobacterium tuberculosis pathogens, make first-line anti-tuberculosis (anti-TB) agents therapeutically more and more ineffective. Therefore, there is an imperative to develop novel highly efficient (synthetic) agents against both drug-sensitive-TB and DR-TB. The exploration of various heterocycles as prospective core scaffolds for the discovery, development and optimization of anti-TB drugs remains an intriguing scientific endeavour.

View Article and Find Full Text PDF